A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Prelude Therapeutics
Prelude Therapeutics
Incyte Corporation
Hangzhou GluBio Pharmaceutical Co., Ltd.
BeBetter Med Inc
Mabwell (Shanghai) Bioscience Co., Ltd.
AbbVie
Vanderbilt-Ingram Cancer Center
Fox Chase Cancer Center
Perseus Proteomics Inc.
Lynk Pharmaceuticals Co., Ltd
Novartis
Case Comprehensive Cancer Center
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Northwestern University
Eli Lilly and Company
California Cancer Consortium
Eli Lilly and Company
Yale University
Alliance for Clinical Trials in Oncology
Icahn School of Medicine at Mount Sinai
Children's Oncology Group
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University
National Institutes of Health Clinical Center (CC)
Exelixis
NYU Langone Health
University of Arizona
Rutgers, The State University of New Jersey